Light and Oxygen: How Photobiomodulation Influences Mitochondria and Why Aerobic ATP Production Depends on Oxygen

In summary

Light and oxygen enter cellular bioenergetics in fundamentally different ways. Oxygen is an essential component of aerobic oxidative phosphorylation: at Complex IV of the mitochondrial electron transport chain, it acts as the terminal electron acceptor and allows respiratory electron flow to continue. Red and near-infrared light does not perform this fundamental metabolic function. Photobiomodulation is a physical stimulus that can alter mitochondrial function, metabolic flux, redox signaling, and other regulatory processes, but it is not a prerequisite for normal ATP production.

This distinction is the foundation of the relationship between Light Systems™ and Oxygen Systems™. Photobiomodulation can modulate how a cell operates within its energy system. Oxygen has a different and more fundamental role: without adequate oxygen availability, normal aerobic electron flow through Complex IV cannot be maintained. This does not mean, however, that all biological effects of PBM depend directly on the amount of oxygen available, or that increasing oxygenation automatically enhances the effects of red light therapy. More recent research shows that the relationship between PBM × mitochondria × oxygen depends on dose, cell type, and metabolic context and cannot be reduced to a simple equation such as “light provides the signal, oxygen completes the effect.”

Light is not ATP, and oxygen is not a stimulant

When discussing cellular energy, three fundamentally different concepts are easily confused: the physical energy carried by photons, the chemical energy stored in metabolic substrates, and ATP as the cell’s immediately usable energy currency.

Photons do, of course, carry energy. When they are absorbed by a biological chromophore or trigger another photophysical interaction, they can initiate further molecular and cellular events. This does not mean, however, that light is a metabolic fuel or that red light therapy directly supplies ATP to the cell.

Likewise, oxygen is not an energy stimulant. Molecular O₂ does not function as “extra energy.” It is part of the mechanism that allows electron flow through the mitochondrial respiratory chain to be completed, thereby supporting oxidative phosphorylation.

The significance of connecting Light Systems™ and Oxygen Systems™ is therefore not:

light + oxygen = energy.

A more accurate formulation is:

light may modulate cellular and mitochondrial responses; oxygen is an essential component of aerobic mitochondrial respiration.

Mitochondria are dynamic energy and regulatory systems

Mitochondria are often described as the “powerhouses of the cell.” This is a useful metaphor, but it can create the impression of a passive generator that simply needs to be supplied with fuel and oxygen.

In reality, mitochondria are dynamic organelles that integrate energy demand, substrate availability, redox state, cellular signaling, Ca²⁺, the availability of ADP and inorganic phosphate, oxygen availability, and many other inputs.

During aerobic oxidative phosphorylation, electrons derived from nutrient metabolism enter the electron transport chain through NADH and FADH₂. Their passage through the respiratory complexes generates an electrochemical proton gradient across the inner mitochondrial membrane. ATP synthase then uses the energy stored in this gradient to produce ATP.

Oxygen enters the process as the terminal electron acceptor

At Complex IV — cytochrome c oxidase — molecular oxygen accepts electrons and, in the presence of protons, is reduced to water. Without O₂, normal aerobic electron flow cannot be maintained.

Oxygen is therefore irreplaceable for this specific process.

Photobiomodulation does not have this role. Cells can produce ATP without exogenous PBM, and healthy mitochondria do not require red or near-infrared light as a basic condition for normal function.

This distinction must remain completely clear within TANVEA.

Cytochrome c oxidase: an important candidate mechanism of PBM, not the only definitive answer

Cytochrome c oxidase is among the longest-studied potential chromophores in photobiomodulation. In many mechanistic models, red and near-infrared light are associated with changes in CCO activity, mitochondrial membrane potential, respiration, ATP production, redox signaling, and nitric oxide availability.

This hypothesis remains biologically important.

The current state of knowledge, however, does not support the claim that CCO is the sole mechanism responsible for all PBM effects.

What newer mechanistic literature shows

A National Institute on Aging expert workshop published in 2025 discussed mitochondrial cytochrome c oxidase alongside modulation of membrane transporters and receptors, activation of TGF-β1, and other potential mechanisms. The conclusion was not that CCO should be rejected, but that the mechanisms of photobiomodulation remain incompletely resolved.

A review published in 2026 again describes CCO as an important site of photon absorption and links PBM with changes in electron transport, ATP, and ROS signaling. At the same time, it emphasizes wavelength-dependent, dose-dependent, and bidirectional responses and highlights the difficulty of standardizing PBM parameters.

For TANVEA, the more accurate framework is therefore:

cytochrome c oxidase is one of the most important candidate mechanisms of photobiomodulation, but PBM cannot be reduced to a single molecule or to a simple CCO → ATP model.

Where do light and oxygen actually intersect?

Their clearest mechanistic intersection occurs in mitochondrial bioenergetics.

If PBM changes mitochondrial respiration, membrane potential, metabolic substrate utilization, or the regulatory state of the respiratory system, the resulting aerobic oxidative phosphorylation still operates in an environment in which O₂ is the terminal electron acceptor.

This does not mean that PBM requires increased oxygen availability for every biological effect.

Nor does it mean that hypoxia automatically prevents a photobiomodulatory response.

PBM can influence cells even in a hypoxic microenvironment

A study published in 2025 examined 808 nm PBM in a three-dimensional culture of human dental pulp stem cells maintained under hypoxic conditions. Photobiomodulation produced dose-dependent changes in mitochondrial respiration and the expression of several osteogenic proteins even within this hypoxic microenvironment. This was a cellular experimental model, not evidence of clinical efficacy, but it clearly shows that biological responses to PBM do not simply disappear when oxygenation is reduced.

A small randomized crossover pilot study in recreational runners compared PBM under normoxic and hypoxic conditions. Hypoxia continued to reduce time to exhaustion and absolute aerobic energy contribution, and PBM did not eliminate this effect. Under hypoxic conditions, however, PBM altered the relative contribution of different energy systems. Because the study included only 11 men, it should be regarded as a mechanistically interesting signal rather than a basis for general practical recommendations.

A very important principle follows:

the relationship between photobiomodulation and oxygen is not binary. PBM may modify cellular responses even under altered oxygenation, while oxygen remains essential for aerobic oxidative phosphorylation itself.

Photobiomodulation may alter metabolic flux, not merely “mitochondrial activity”

An older popular PBM model often looks approximately like this:

light → CCO → more ATP.

More recent experimental work suggests that reality may be broader.

A 2025 study in human keratinocytes found that red light increased both basal and maximal oxygen consumption and activated AMPK-dependent mitochondrial fatty-acid oxidation without increasing the abundance of electron transport chain proteins. This suggests that a light stimulus may also influence metabolic flux and substrate utilization, rather than simply increasing the “activity of the powerhouse.”

Such findings cannot automatically be extrapolated from a specific cellular model to the entire human organism. Their value lies primarily in expanding mechanistic thinking about PBM.

Photobiomodulation may influence:

mitochondrial respiration, metabolic substrate selection, redox signaling, membrane processes, and downstream signaling pathways.

It is therefore scientifically more accurate to speak about modulation of cellular metabolism rather than simply “charging mitochondria.”

In PBM, dose, wavelength, cell type, and biological context matter

A major theme in more recent literature is the bidirectional or biphasic response.

PBM does not follow a linear rule:

more light → greater biological effect.

A study comparing 660 nm and 830 nm exposures demonstrated different ATP and ROS responses depending on wavelength, fluence, and cell type. Myoblasts showed a characteristic biphasic response, with peak ATP production at a particular dose, whereas adenocarcinoma cells responded differently. This is again a cellular model, but it supports a fundamental PBM principle: the biologically effective dose is not the maximum physical output.

Likewise, a 2026 review emphasizes that PBM effects are strongly dependent on wavelength and dose and that variability in treatment parameters remains one of the major obstacles to consistent interpretation of clinical outcomes.

For TANVEA Light Systems™, the correct principle is therefore:

dose, not maximum.

Within Light × Oxygen, this adds another layer:

a light stimulus cannot be evaluated independently of the cell’s metabolic and oxygenation context.

ROS are not a simple link between light and reduced oxygen availability

Older models often presented a relatively simple narrative: reduced O₂ slows electron transport, more electrons leak, and mitochondrial ROS increase.

That equation is no longer sufficiently precise.

Mitochondrial ROS have both physiological and pathological roles. Within an appropriate range, they participate in cellular signaling. When produced excessively or when redox control is inadequate, they may contribute to oxidative damage.

Hypoxia does not automatically mean more mitochondrial ROS

A 2024 review shows that results from hypoxia studies vary substantially depending on cell type, actual pericellular oxygen concentration, duration of hypoxia, whether isolated mitochondria or intact cells are used, and the analytical methodology employed.

An experimental study from the same year also observed a decrease — not an increase — in superoxide and H₂O₂ production from several major mitochondrial and cytoplasmic sources during acute hypoxia in HEK293 cells.

The same rule therefore applies here as in Oxygen Systems™ article No. 2:

altered oxygen availability changes cellular redox dynamics, but it cannot be universally stated that less O₂ automatically means more mitochondrial ROS.

Why even the best red light panel is not an entire biological system

The outcome of PBM does not depend only on device quality. Wavelength, spectral composition, irradiance, fluence, distance, exposure time, treated area, tissue optical properties, and application method all influence the physical dose.

Yet even these parameters do not fully explain the biological response.

Responses may differ according to cell type, metabolic state, local tissue environment, and the specific biological endpoint being measured. Contemporary PBM literature identifies this variability as one of the main reasons why the results of one protocol cannot simply be extrapolated to another wavelength, another dose, or another biological system.

TANVEA systems thinking therefore does not need to create unsupported causal claims such as “stress blocks red light therapy.” A more precise framework is stronger:

photobiomodulation enters a living organism whose metabolic and regulatory state influences its biological response to a physical stimulus.

This is why Light Systems™ should not be understood as an isolated table of wavelengths and output values.

A mild hyperbaric environment changes oxygenation conditions, not automatically “the effectiveness of light”

When connecting Light Systems™ and Oxygen Systems™, it is tempting to assume that increased oxygen availability automatically enhances PBM.

There is currently insufficient evidence to support such a general claim.

What we can say precisely is different: depending on pressure and the concentration of inhaled O₂, a hyperbaric environment can alter oxygen partial pressure and the amount of O₂ physically dissolved in plasma. In this way, it can change the oxygenation conditions of the organism.

Whether, and under what circumstances, this produces a stronger, weaker, or simply different response to PBM must be established through specific research and cannot be inferred from the basic biochemistry of Complex IV alone.

Pressure, inhaled O₂ concentration, and time all matter

ATA alone is not sufficient to characterize oxygen exposure.

The resulting O₂ partial pressure depends on:

total pressure × inspired oxygen fraction

and the biological dose also depends on time.

As oxygen partial pressure rises, Henry’s law predicts an increase in the amount of O₂ physically dissolved in plasma. The magnitude of this effect, however, differs substantially between hyperbaric protocols.

Mild hyperbaric exposure is not medical HBOT

Recent reviews published in 2026 describe this distinction very clearly.

Traditional medical HBOT uses higher pressures and high concentrations of inhaled oxygen, whereas “mild” protocols use lower pressures and generally produce a different oxygen exposure. They are therefore physiologically different exposure regimes. Mild hyperbaric use also remains substantially less studied for several claimed purposes.

Another 2026 review notes that HBOT and mHBOT are often incorrectly used as synonyms despite differences in pressure, inspired O₂ fraction, and the resulting amount of oxygen dissolved in plasma.

For TANVEA, the principle is therefore:

a mild hyperbaric environment should not be presented as a weaker version of medical HBOT or as an automatic enhancer of photobiomodulation.

It is a separate physical input that alters pressure and oxygenation conditions.

Light Systems™ and Oxygen Systems™: a biological intersection without artificial dependence

Light Systems™ and Oxygen Systems™ have a genuine biological intersection.

Not because mitochondria would be unable to produce ATP without red light therapy.

And not because increasing oxygen would automatically increase the effect of PBM.

Their intersection arises because photobiomodulation may alter mitochondrial function and energy regulation within a system whose aerobic oxidative phosphorylation depends on oxygen.

That is a scientifically much stronger relationship.

Light is a modulatory physical input.

Oxygen is an essential molecular component of aerobic respiration.

Their effects may intersect biologically, but each system retains its own mechanistic identity.

TANVEA Biological Systems™: integration does not mean mixing mechanisms

TANVEA Biological Systems™ should not create a narrative in which every system enhances every other system.

Their value is precisely the opposite: they allow different physical and biological inputs to be distinguished first, and only then allow us to examine where their effects genuinely intersect.

Hydro Systems™ work with the physical properties of water and their physiological consequences.

Thermal Systems™ work with thermal exposure and thermoregulatory responses.

Light Systems™ work with photobiomodulatory input and its biological interpretation.

Oxygen Systems™ work with oxygen availability and the conditions governing its transport and utilization.

Hydrogen Systems™ work with the biological effects of molecular hydrogen and redox regulation.

These systems may influence one another. TANVEA, however, should always distinguish between a demonstrated mechanism, a biologically plausible interaction, and a hypothesis that still requires verification.

That is what prevents systems thinking from becoming a marketing shortcut.

Key message

Mitochondria do not require exogenous red or near-infrared light as a basic condition for normal ATP production.

Oxygen, however, is irreplaceable in aerobic mitochondrial respiration: at Complex IV, it acts as the terminal electron acceptor and allows oxidative phosphorylation to continue.

Photobiomodulation has a different role.

It may alter mitochondrial function, metabolic flux, redox signaling, and other regulatory processes, with its effects depending on wavelength, dose, cell type, and biological context. Current research also does not support explaining all PBM effects through cytochrome c oxidase alone.

The most accurate description of the relationship between Light Systems™ and Oxygen Systems™ is therefore:

light may modulate mitochondrial and cellular responses; oxygen remains an essential component of aerobic oxidative phosphorylation itself.

They are not two equivalent signals.

They are not two equivalent conditions.

And one does not replace the other.

Their biological intersection occurs within the cell’s energy system — precisely where regulatory inputs meet metabolic reality.

FAQ

Do mitochondria need red light to produce ATP?

No. Healthy mitochondria do not require exogenous photobiomodulation as a basic condition for normal ATP production. PBM may modulate mitochondrial function, but it is not an essential component of oxidative phosphorylation.

Why do mitochondria need oxygen?

Molecular oxygen acts as the terminal electron acceptor at Complex IV. In this role, it allows the electron transport chain and aerobic oxidative phosphorylation to continue.

Is cytochrome c oxidase the main target of red light therapy?

CCO is among the most important proposed chromophores and mechanisms of PBM, but current literature also discusses membrane receptors, transporters, and other signaling mechanisms. It should therefore not be regarded as the definitive sole explanation for all PBM effects.

Does PBM increase ATP?

Not always. ATP production and mitochondrial respiration can be influenced by PBM, but the response depends on wavelength, dose, cell type, and biological state. PBM often exhibits a biphasic response in which a higher dose does not necessarily produce a larger biological effect.

Does photobiomodulation work under hypoxia?

A biological response to PBM can occur even in a hypoxic environment. A 2025 experimental study demonstrated dose-dependent changes in mitochondrial respiration after 808 nm PBM in a hypoxic 3D cell culture. This does not mean that oxygen ceases to be necessary for aerobic oxidative phosphorylation.

Does less oxygen automatically mean more mitochondrial ROS?

No. More recent research shows that the direction of change in mitochondrial ROS production during hypoxia depends on the cellular model, the severity and duration of hypoxia, and the measurement methodology.

Does more oxygen automatically increase the effect of red light therapy?

Such a general claim is not currently supported. Increased oxygen availability may alter oxygenation conditions, but it cannot be assumed that it enhances every effect of PBM.

Is a mild hyperbaric environment the same as medical HBOT?

No. They differ in pressure, inspired oxygen concentration, resulting O₂ partial pressure, and total oxygen exposure. Mild hyperbaric protocols also remain substantially less studied for several applications.

---

Safety and professional notice

The content of this article is intended for educational and informational purposes. It is not intended to diagnose or treat any specific disease and does not replace individual medical assessment, medical care, or the advice of a qualified healthcare professional.

Photobiomodulation and hyperbaric environments are distinct physical exposures with their own parameters, indications, limitations, and safety requirements. Outcomes cannot be assessed solely on the basis of light wavelength, device output, or pressure expressed in ATA. In PBM, relevant variables include wavelength, irradiance, fluence, exposure time, treated area, and application method. In hyperbaric systems, exposure depends on pressure, inhaled oxygen concentration, time, device type, technical conditions, health status, and individual tolerance.

In 2025, the U.S. Food and Drug Administration drew attention to reports of serious injuries and deaths associated with HBOT devices and emphasized compliance with manufacturer instructions, fire-safety measures, training, supervision, maintenance, and technical inspections.

If you have health problems, take medication, are under medical care, or are uncertain about the suitability of photobiomodulation, a hyperbaric environment, or a combination of different physical exposures in your specific situation, consult a qualified healthcare professional before use.

TANVEA Light Systems™ and TANVEA Oxygen Systems™ in a non-medical context do not replace diagnosis, treatment, medical hyperbaric oxygen therapy, or any other form of healthcare.

---

SCIENTIFIC SOURCES AND REFERENCES

Frankowski DW, Ferrucci L, Arany PR, et al. Light buckets and laser beams: mechanisms and applications of photobiomodulation (PBM) therapy. GeroScience. 2025. Output from a National Institute on Aging expert workshop; important for the contemporary view of multiple possible PBM mechanisms and the uncertainty surrounding any single dominant mechanism.

Shi G, Wei K, Wang R, et al. Mechanisms of action and clinical research progress of photobiomodulation. Journal of Photochemistry and Photobiology B: Biology. 2026. Current review of PBM mechanisms, CCO, mitochondrial bioenergetics, redox signaling, and dose-dependent responses.

Sleep SL, Ranjit E, Gunter J, et al. Mitochondrial Oxygen Consumption and Immunocytochemistry of Human Dental Pulp Stem Cell Following 808 nm PBM Therapy: A 3D Cell Culture Study. Journal of Biophotonics. 2025. Experimental PBM model in a hypoxic microenvironment.

Secarolli LF, de Carvalho CD, Girasol CE, et al. Influence of photobiomodulation on energy contribution in normoxia and hypoxia conditions in amateur runners: a single-blinded and randomized crossover pilot study. Lasers in Medical Science. 2024. Small pilot study examining the interaction between PBM and hypoxia during physical exercise.

Mitochondrial fatty acid oxidation is stimulated by red light irradiation. FEBS Letters. 2025. Experimental work showing AMPK-dependent stimulation of mitochondrial fatty-acid oxidation and increased basal and maximal oxygen consumption in keratinocytes after red-light exposure.

Safe Mitochondrial Activation Through Photobiomodulation: Distinct Red and Near-Infrared Responses in Normal and Malignant Cells. 2025/2026. Experimental work supporting wavelength-, dose-, and cell-type-dependent ATP and ROS responses.

Alva R, Wiebe JE, Stuart JA. Revisiting reactive oxygen species production in hypoxia. Pflügers Archiv. 2024. Key reference for a more nuanced interpretation of hypoxia × ROS.

Sen B, Benoit B, Brand MD. Hypoxia decreases mitochondrial ROS production in cells. Free Radical Biology and Medicine. 2024. Experimental work showing reduced mitochondrial ROS production during acute hypoxia in the cellular model studied.

Johnson-Arbor K. Mild and Traditional Hyperbaric Oxygenation: Clinical Uses and Safety Considerations. Undersea & Hyperbaric Medicine. 2026. Current review of differences and safety considerations between mild and traditional hyperbaric oxygenation.

Morningstar M, Strauchman M. Hyperbaric Oxygen Therapy and Mild Hyperbaric Oxygen Therapy Are Not Synonymous: A Narrative Review. 2026. Supplementary source concerning differences in pressure, O₂ concentration, and resulting oxygen exposure; because of the authors’ professional ties to hyperbaric practice, it should be used as supplementary rather than sole authoritative evidence.

U.S. Food and Drug Administration. Follow Instructions for Safe Use of Hyperbaric Oxygen Therapy Devices – Letter to Health Care Providers. August 25, 2025. Current safety reference.

Karu TI. Primary and secondary mechanisms of action of visible to near-IR radiation on cells. Journal of Photochemistry and Photobiology B. 1999.

Hamblin MR. Mechanistic literature on mitochondrial and redox signaling in photobiomodulation.

Quirk BJ et al. Light, Cytochrome C Oxidase, and Nitric Oxide. Photobiomodulation, Photomedicine, and Laser Surgery. 2020.

Nelson DL, Cox MM. Lehninger Principles of Biochemistry.

Hall JE. Guyton and Hall Textbook of Medical Physiology.